Robert Pelletier is an experienced research leader currently at Schrödinger since April 2020, specializing in drug metabolism, PBPK modeling, and PK/PD modeling, while also supervising and mentoring team members. Prior to this role, Robert served as a Senior Principal Scientist at the University of Washington and as a Research Scientist and Acting Lecturer at Eisai Inc., where responsibilities included conducting experiments on drug metabolism liabilities, developing LC/MS methods, and collaborating on toxicology assays. Robert holds a Ph.D. in Medicinal Chemistry from the University of Washington and a B.A. in Biology/Chemistry from Assumption University, with additional education at UMass Chan Medical School.
This person is not in any teams
This person is not in any offices